A recent study shows that computer algorithms can be used to find molecules that can be developed into anti-inflammatory ...

Secretary Robert F. Kennedy Jr. has made psychiatric medications a focus of his review of the country’s childhood chronic ...

Molecular crystal polymorphism does not sound like something you want in your kitchen, but you've probably had experience ...

Research by UMass Chan Medical School scientists Sharon Cantor, Ph.D., and Jenna M. Whalen, Ph.D., poses a new explanation ...

A series of events leads to a tragedy at Three Rock and Bode possibly back on drugs. Read the Fire Country Season 3 Episode ...

I don’t consider myself a “square” but I’m having a hard time reconciling some relationships. My cousin‘s family now owns a ...

Janus kinase (JAK) inhibitors look to be a good treatment option for the newly recognized, rare autoimmune disease known as ...

Eli Lilly is now offering four doses of Zepbound in self-administration vials. The lower-cost self-pay option targets people on Medicare and those who can no longer access compounded tirzepatide.

HER2 (also known as ERBB2) is a key oncogene in breast cancer and is found in 2–4% of patients with non-small-cell lung ...

Pharmaceutical giant Eli Lilly is once again expanding the supply of its weight-loss drug Zepbound and cutting the cost for patients that don't have insurance.

At a press conference in Washington, D.C., Eli Lilly And Co (NYSE:LLY) announced its plans to bolster its domestic medicine ...